BHST
BHST
NASDAQ · Consumer products

Bioharvest Sciences Inc

$4.47
+0.14 (+3.23%)
As of Mar 25, 3:55 PM ET ·
Financial Highlights (FY 2026)
Revenue
25.04M
Net Income
-24,826,659
Gross Margin
44.4%
Profit Margin
-99.2%
Rev Growth
+217.5%
D/E Ratio
0.93
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.4% 48.9% 48.9% 48.9%
Operating Margin -78.6% 10.7% 11.8% 10.5%
Profit Margin -99.2% 11.5% 10.8% 10.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 25.04M 79.81M 72.35M 77.50M
Gross Profit 11.13M 39.05M 35.41M 37.92M
Operating Income -19,694,424 8.54M 8.53M 8.10M
Net Income -24,826,659 9.14M 7.84M 7.97M
Gross Margin 44.4% 48.9% 48.9% 48.9%
Operating Margin -78.6% 10.7% 11.8% 10.5%
Profit Margin -99.2% 11.5% 10.8% 10.3%
Rev Growth +217.5% +14.6% +12.0% -2.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 28.50M 71.15M 71.70M 68.34M
Total Equity 30.60M 76.04M 83.93M 92.20M
D/E Ratio 0.93 0.94 0.85 0.74
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -21,962,662 10.94M 9.97M 9.95M
Free Cash Flow 7.79M 6.73M 8.70M